What is the enterprise value (EV) for AxoGen, Inc. (AXGN)?

The enterprise value (EV) for AXGN stock is $2.03B.

AxoGen (AXGN) Enterprise Value: History & Chart

Compare

AxoGen, Inc.(AXGN)

Medical - Devices · Alachua, FL

$37.49+0.27 (+0.73%)

Delayed quote: Oct 6, 2026, 10:10 AM EDT

Compare

About AxoGen, Inc.

AxoGen, Inc., along with its subsidiaries, specializes in creating and distributing medical devices for the surgical repair of injured or severed peripheral nerves. Their comprehensive product portfolio offers several innovative solutions. The Avance Nerve Graft is a ready-to-use, biologically active human nerve allograft designed to bridge gaps in severed nerves. This avoids the need for a second surgical site for tissue donation, thereby eliminating associated complications. For facilitating the gentle reconnection of severed peripheral nerves, the company offers the AxoGuard Nerve Connector, an extracellular matrix (ECM) derived from porcine submucosa. This same porcine submucosa ECM forms the basis of the AxoGuard Nerve Protector, which is utilized to encase and safeguard damaged peripheral nerves, supporting their reconstruction and preventing unwanted adhesions from surrounding soft tissues. Another ECM product, the AxoGuard Nerve Cap, isolates the nerve end from its environment to help mitigate the formation of painful neuromas. Furthermore, AxoGen provides the Avive Soft Tissue Membrane, a processed human umbilical cord membrane that functions as an absorbable covering for soft tissues, used to separate tissues within the surgical area. An additional tool available is the AxoTouch two-point discriminator, used for evaluating the density of nerve innervation on the skin's surface. These products are supplied to hospitals, surgery centers, and military medical facilities, catering to plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen's market reach extends across the United States, Canada, Germany, the United Kingdom, other European nations, South Korea, and internationally. The company's main operations are situated in Alachua, Florida.

Alachua, FL

622 employees

www.axogeninc.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Michael D. Dale

View full financials

NAME	MARKET CAP	ENTERPRISE VALUE (EV)
AxoGen, Inc. (AXGN)	$2.02B	$2.03B
Immunome, Inc. (IMNM)vs ›	$1.99B	$1.77B
Aurinia Pharmaceuticals Inc. (AUPH)vs ›	$2.01B	$1.89B
Inspire Medical Systems, Inc. (INSP)vs ›	$2.02B	$1.92B
Mineralys Therapeutics, Inc. (MLYS)vs ›	$2.02B	$1.98B
Azenta, Inc. (AZTA)vs ›	$2.03B	$1.90B
BioCryst Pharmaceuticals, Inc. (BCRX)vs ›	$2.04B	$2.29B
Establishment Labs Holdings Inc. (ESTA)vs ›	$1.95B	$2.14B
Alvotech (ALVO)vs ›	$2.07B	$3.38B
Addus HomeCare Corporation (ADUS)vs ›	$2.10B	$2.11B

NAME

MARKET CAP

ENTERPRISE VALUE (EV)

AxoGen, Inc. (AXGN)

$2.02B

$2.03B

Immunome, Inc. (IMNM)vs ›

$1.99B

$1.77B

Aurinia Pharmaceuticals Inc. (AUPH)vs ›

$2.01B

$1.89B